Lasa Supergenerics appoints CFO, director

Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns

Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders

Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up

Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps

Lasa Supergenerics Ltd. named Ravi Shankar Kabra as its CFO.

According to Lasa, Kabra brings to the company his core capabilities in accounts, finance, credit control, operations and cost rationalization.

The Indian pharmaceutical company also added Mithun Jadhav to its board as a whole time director.

He previously worked with Kansai Nerolac Paints Ltd., Valvoline Cummins Ltd., Nippon Paint India Pvt. Ltd. and Deepak Novochem Ltd.